5 / 8
Volume 2
Journal of Clinical Diagnosis and Treatment
Annual Nephrology & Chronic Diseases 2019
May 20-21, 2019
Page 14
Notes:
Nephrology
Chronic Diseases
May 20-21, 2019 London, UK
19
th
Annual Conference on
3
rd
International Conference on
&
controls TSH and FT4 every 6-12 months. Lasting the therapy in the 50- 90% of the cases is assisted
to a reduction of the thyroid volume and consistence both for the normalization of the values of TSH
and for the reduction of the lymphocytic infiltrate. Besides it is also assisted to a reduction of the
antibodies title, to which has been shown the association it contributes using selenium and vitamin D.
Biography
Francesco Lippi has completed his M.D degree from the University of Pisa Medical School in 1978 and has completed his speciality degree
from University of Pisa Postgraduate School of Endocrinology in the year 1983. He also holds a speciality degree in nuclear medicine from
the University of France. He is currently the Professor of Endocrinology in the School of Endocrinology, University of Pisa. He is also the
Editorial Board of EC Endocrinology and Metabolism
f.lippi.doc@gmail.com